Free Trial

Emprise Bank Has $1.05 Million Stake in Oracle Corporation $ORCL

Oracle logo with Computer and Technology background

Key Points

  • Emprise Bank reduced its stake in Oracle Corporation by 26%, owning 4,790 shares valued at approximately $1.05 million after selling 1,687 shares in Q2.
  • Analysts have raised Oracle's target prices significantly, with Stifel Nicolaus setting a new target at $350 and Wolfe Research at $400, reflecting positive market sentiment.
  • Oracle recently announced a quarterly $0.50 dividend per share, translating to a 0.7% dividend yield and scheduled for payment on October 23.
  • Five stocks we like better than Oracle.

Emprise Bank decreased its stake in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 26.0% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 4,790 shares of the enterprise software provider's stock after selling 1,687 shares during the period. Emprise Bank's holdings in Oracle were worth $1,047,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. Sunbeam Capital Management LLC bought a new stake in Oracle during the 4th quarter valued at approximately $30,000. Redmont Wealth Advisors LLC bought a new stake in Oracle during the 1st quarter valued at approximately $27,000. Inlight Wealth Management LLC bought a new stake in Oracle during the 1st quarter valued at approximately $28,000. Iron Horse Wealth Management LLC boosted its stake in Oracle by 284.9% during the 1st quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider's stock valued at $29,000 after purchasing an additional 151 shares during the period. Finally, Mpwm Advisory Solutions LLC bought a new stake in Oracle during the 4th quarter valued at approximately $36,000. Institutional investors and hedge funds own 42.44% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ORCL. Stifel Nicolaus increased their target price on Oracle from $250.00 to $350.00 and gave the company a "buy" rating in a research note on Wednesday, September 10th. JPMorgan Chase & Co. raised their price objective on Oracle from $185.00 to $210.00 and gave the stock a "neutral" rating in a research report on Monday, September 8th. Citigroup restated an "outperform" rating on shares of Oracle in a research report on Wednesday, September 10th. UBS Group set a $300.00 target price on Oracle in a research report on Wednesday, September 10th. Finally, Wolfe Research raised their target price on Oracle from $300.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, September 10th. Two analysts have rated the stock with a Strong Buy rating, twenty-four have given a Buy rating and nine have issued a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $303.44.

View Our Latest Research Report on Oracle

Insider Transactions at Oracle

In other news, EVP Maria Smith sold 10,000 shares of Oracle stock in a transaction on Thursday, July 3rd. The stock was sold at an average price of $232.99, for a total value of $2,329,900.00. Following the completion of the sale, the executive vice president directly owned 40,807 shares of the company's stock, valued at approximately $9,507,622.93. This trade represents a 19.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Rona Alison Fairhead bought 480 shares of the stock in a transaction dated Monday, July 7th. The stock was purchased at an average cost of $233.87 per share, with a total value of $112,257.60. Following the completion of the purchase, the director directly owned 22,110 shares in the company, valued at approximately $5,170,865.70. This trade represents a 2.22% increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 29,183 shares of company stock valued at $7,141,698 over the last quarter. Corporate insiders own 42.20% of the company's stock.

Oracle Trading Up 3.4%

ORCL stock opened at $302.10 on Tuesday. The business has a fifty day moving average price of $246.08 and a 200 day moving average price of $191.63. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72. The stock has a market capitalization of $858.48 billion, a price-to-earnings ratio of 69.93, a P/E/G ratio of 3.16 and a beta of 1.46. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62.

Oracle Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle's dividend payout ratio (DPR) is 46.30%.

About Oracle

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Further Reading

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oracle Right Now?

Before you consider Oracle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.

While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

He Said Sell Oracle. Here’s What Happened Next.
3 Stocks With Explosive Upside
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines